Oncology: What You May Have Missed in 2023

Courtney H Coschi1, Lorin Dodbiba1, DuPont Guerry2

  • 1Division of Medical Oncology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada (C.H.C., L.D.).

PubMed

Insights

This review covers 2023 oncology advances for non-oncologist physicians, focusing on social interventions, cancer screenings, hormone therapies, and COVID-19 vaccination in cancer patients.

Area of Science:

  • Oncology
  • Internal Medicine
  • Public Health

Background:

  • Cancer treatment advances improve patient outcomes and quality of life.
  • Complex cancer care necessitates multidisciplinary physician collaboration.
  • Evidence review targets non-oncologist specialists managing cancer patients.

Purpose of the Study:

  • Highlight significant 2023 publications relevant to oncology patient management.
  • Provide crucial updates for internal medicine specialists and subspecialists.
  • Synthesize new evidence across diverse oncology-related topics.

Main Methods:

  • Literature screening of 2023 publications.
  • Focus on evidence relevant to non-oncology specialists.
  • Categorization of articles by topic: social interventions, screening, therapies, and COVID-19.

Main Results:

  • Key findings on social interventions for end-of-life care and caregiver well-being.
  • Updated screening guidelines for colorectal and lung cancer risk.
  • Evidence on safe hormone-related therapies for noninvasive breast neoplasia.
  • Insights into COVID-19 vaccination, cannabinoid use for pain, immune checkpoint inhibitor side effects, and second primary neoplasms.

Conclusions:

  • Non-oncologist physicians require updated knowledge on diverse oncology topics.
  • Social determinants and targeted therapies are critical in cancer care.
  • Ongoing research addresses survivorship, adverse effects, and emerging challenges in oncology.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K